Trial Profile
Effect of imiglucerase in US patients with Gaucher disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Apr 2015
Price :
$35
*
At a glance
- Drugs Imiglucerase (Primary)
- Indications Gaucher's disease
- Focus Therapeutic Use
- 30 Apr 2015 New trial record